TY - JOUR AU - Baranašić, Jurica AU - Šutić, Maja AU - Catalano, Calogerina AU - Drpa, Gordana AU - Huhn, Stefanie AU - Majhen, Dragomira AU - Nestić, Davor AU - Kurtović, Matea AU - Rumora, Lada AU - Bosnar, Martina AU - Vukić Dugac, Andrea AU - Sokolović, Irena AU - Popovic-Grle, Sanja AU - Oršolić, Nada AU - Škrinjarić-Cincar, Sanda AU - Jakopović, Marko AU - Samaržija, Miroslav AU - Weber, Alexander N R AU - Försti, Asta AU - Knežević, Jelena TI - TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line. JO - Biomedicines VL - 10 IS - 9 SN - 2227-9059 CY - Basel PB - MDPI M1 - DKFZ-2022-02242 SP - 2240 PY - 2022 N1 - #LA:B062# AB - Chronic obstructive pulmonary disease (COPD) is considered as the strongest independent risk factor for lung cancer (LC) development, suggesting an overlapping genetic background in both diseases. A common feature of both diseases is aberrant immunity in respiratory epithelia that is mainly regulated by Toll-like receptors (TLRs), key regulators of innate immunity. The function of the flagellin-sensing TLR5 in airway epithelia and pathophysiology of COPD and LC has remained elusive. We performed case-control genetic association and functional studies on the importance of TLR5 in COPD and LC development, comparing Caucasian COPD/LC patients (n = 974) and healthy donors (n = 1283). Association analysis of three single nucleotide polymorphisms (SNPs) (rs725084, rs2072493_N592S, and rs5744174_F616L) indicated the minor allele of rs2072493_N592S to be associated with increased risk for COPD (OR = 4.41, p < 0.0001) and NSCLC (OR = 5.17, p < 0.0001) development and non-small cell LC risk in the presence of COPD (OR = 1.75, p = 0.0031). The presence of minor alleles (rs5744174 and rs725084) in a co-dominant model was associated with overall survival in squamous cell LC patients. Functional analysis indicated that overexpression of the rs2072493_N592S allele affected the activation of NF-κB and AP-1, which could be attributed to impaired phosphorylation of p38 and ERK. Overexpression of TLR5N592S was associated with increased chemosensitivity in the H1299 cell line. Finally, genome-wide transcriptomic analysis on WI-38 and H1299 cells overexpressing TLR5WT or TLR5N592S, respectively, indicated the existence of different transcription profiles affecting several cellular pathways potentially associated with a dysregulated immune response. Our results suggest that TLR5 could be recognized as a potential biomarker for COPD and LC development with functional relevance. KW - COPD (Other) KW - NSCLC (Other) KW - SNP (Other) KW - TLR5 (Other) KW - chemoresistance (Other) KW - survival (Other) LB - PUB:(DE-HGF)16 C6 - pmid:36140341 DO - DOI:10.3390/biomedicines10092240 UR - https://inrepo02.dkfz.de/record/181827 ER -